INS and metabolic dysfunction-associated steatotic liver disease: In a study of 26,527 subjects undergoing medical checkups in China, the prevalence of NAFLD by abdominal ultrasound was 31% in men and 16% in women.23 Similarly, a population based study in India demonstrated a 25% prevalence of NAFLD in men compared with 14% in women.24 The prevalence of NAFLD in the Dallas Heart Study was 42% in white men compared with only 24% in white women and this difference was not attributable to differences in body weight or insulin sensitivity.21 However, this study found no gender difference in the prevalence of NAFLD in Hispanic and Black Americans.